Jing Ji

Chief Tech/Sci/R&D Officer en ABBISKO CAYMAN LIMITED .

54 años

Health Technology

Consumer Services

Perfil

Jing Ji is currently the Chief Medical Officer at Abbisko Cayman Ltd.
Prior to this, he held the position of Vice President at AstraZeneca PLC from 2015 to 2020, Head-Medical Affairs at GSK Plc from 2006 to 2010, Manager-Clinical Development at Sanofi SA from 2003 to 2005, and Manager-Clinical Research at Merck Sharp & Dohme (China) Ltd.
from 1997 to 2003.
He also briefly served as Senior VP-Medical & Clinical Development at Shanghai Lianbio Development Co., Ltd.
from 2020 to 2021.
Dr. Ji received his undergraduate and graduate degrees from Fudan University in 1993 and 1995, respectively, and his graduate degree from Shanghai Second Medical University in 1995.

Cargos activos de Jing Ji

Empresas	Cargo	Inicio
ABBISKO CAYMAN LIMITED	Chief Tech/Sci/R&D Officer	01/02/2021

Todos los cargos activos de Jing Ji

Antiguos cargos conocidos de Jing Ji.

Empresas	Cargo	Fin
Shanghai Lianbio Development Co., Ltd. Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of LianBio, Shanghai Lianbio Development Co., Ltd. is a private company that manufactures paradigm-shifting medicines to patients. The company is based in Shanghai, China. The CEO of the Chinese company is Debra Yu.	Chief Tech/Sci/R&D Officer	01/01/2021
ASTRAZENECA PLC	Corporate Officer/Principal	01/05/2020
GSK PLC	Chief Tech/Sci/R&D Officer	01/01/2010
Sanofi SA	Corporate Officer/Principal	01/09/2005
Merck Sharp & Dohme (China) Ltd.	Corporate Officer/Principal	01/03/2003

Ver el detalle de la experiencia de Jing Ji.

Formación de Jing Ji.

Fudan University	Undergraduate Degree
Shanghai Second Medical University	Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jing Ji.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	3
ASTRAZENECA PLC	Health Technology
GSK PLC	Health Technology
ABBISKO CAYMAN LIMITED	Health Technology

Empresas privadas	3
Sanofi SA	Health Technology
Merck Sharp & Dohme (China) Ltd.
Shanghai Lianbio Development Co., Ltd. Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of LianBio, Shanghai Lianbio Development Co., Ltd. is a private company that manufactures paradigm-shifting medicines to patients. The company is based in Shanghai, China. The CEO of the Chinese company is Debra Yu.	Health Technology

Ver las conexiones de la empresa